Chembond Material Technologies Ltd

Chembond Material Technologies Ltd

₹ 177 -1.56%
11 Aug 10:31 a.m.
About

Incorporated in 1974, Chembond Chemicals Ltd manufactures and sells specialty chemicals and animal health products.[1]

Key Points

Business Overview:[1][2]
CCL manufactures specialty chemicals like high-performance coatings, automotive sealants,
metal treatment chemicals, engineering adhesives, vitamins & minerals, probiotics,
and prebiotic enzymes, and feed additives and nutrition products related to animal health, and industrial biotech products.

  • Market Cap 238 Cr.
  • Current Price 177
  • High / Low 500 / 170
  • Stock P/E 10.2
  • Book Value 117
  • Dividend Yield 0.99 %
  • ROCE 11.5 %
  • ROE 10.5 %
  • Face Value 5.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 23.8%
  • Company's working capital requirements have reduced from 44.6 days to 24.8 days

Cons

  • The company has delivered a poor sales growth of -5.54% over past five years.
  • Company has a low return on equity of 6.71% over last 3 years.
  • Earnings include an other income of Rs.11.5 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
97.65 110.14 110.62 122.03 113.54 112.02 114.60 47.09 46.27 123.53 53.05 52.21 57.68
96.66 100.93 99.46 108.81 104.59 97.51 100.44 44.01 42.83 110.87 49.27 48.61 54.21
Operating Profit 0.99 9.21 11.16 13.22 8.95 14.51 14.16 3.08 3.44 12.66 3.78 3.60 3.47
OPM % 1.01% 8.36% 10.09% 10.83% 7.88% 12.95% 12.36% 6.54% 7.43% 10.25% 7.13% 6.90% 6.02%
0.40 1.10 1.46 1.67 3.01 9.31 3.59 0.89 2.09 6.93 0.19 1.72 2.65
Interest 0.14 0.19 0.21 0.50 0.26 0.46 0.32 0.20 0.16 0.31 0.18 0.14 0.07
Depreciation 1.05 1.08 1.07 1.31 1.06 1.47 1.38 0.88 0.57 1.86 0.68 0.70 0.68
Profit before tax 0.20 9.04 11.34 13.08 10.64 21.89 16.05 2.89 4.80 17.42 3.11 4.48 5.37
Tax % 770.00% 14.05% 26.72% 22.48% 17.39% 29.79% 16.01% 47.75% 2.29% 20.49% -4.18% 25.22% 25.70%
-1.34 7.77 8.25 10.19 8.78 15.35 13.49 1.51 4.68 13.85 3.24 3.36 3.99
EPS in Rs -1.02 5.77 6.16 7.61 6.54 11.52 10.07 1.13 3.49 10.35 2.42 2.51 2.98
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
274 299 270 291 327 301 268 274 349 440 178 201 286
253 273 259 274 304 275 258 256 332 405 172 188 263
Operating Profit 21 26 11 17 23 26 10 18 17 35 7 14 24
OPM % 8% 9% 4% 6% 7% 8% 4% 7% 5% 8% 4% 7% 8%
1 1 189 18 11 4 3 15 9 5 14 9 11
Interest 4 4 2 1 1 1 1 0 1 1 1 1 1
Depreciation 3 4 4 4 4 4 4 5 4 5 3 3 4
Profit before tax 15 20 195 30 28 24 8 29 21 34 17 19 30
Tax % 40% 28% 20% 24% 16% 19% 61% 28% 32% 26% 33% 10%
9 14 156 23 24 20 3 20 14 25 11 18 24
EPS in Rs 5.76 9.24 114.66 14.43 16.40 12.93 1.40 15.18 10.39 18.73 8.34 13.10 18.26
Dividend Payout % 26% 16% 4% 11% 11% 16% 144% 15% 48% 16% 42% 13%
Compounded Sales Growth
10 Years: -4%
5 Years: -6%
3 Years: -17%
TTM: -10%
Compounded Profit Growth
10 Years: 2%
5 Years: 54%
3 Years: 4%
TTM: -34%
Stock Price CAGR
10 Years: 1%
5 Years: 8%
3 Years: 13%
1 Year: -61%
Return on Equity
10 Years: 7%
5 Years: 6%
3 Years: 7%
Last Year: 10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 7 7 7 7 7 7 7 7 7 7 7 7
Reserves 80 89 200 223 242 255 262 286 297 315 137 149
33 25 11 9 9 7 3 2 2 7 7 3
86 83 72 82 68 54 50 59 56 74 41 43
Total Liabilities 205 203 289 321 325 322 322 354 361 402 191 202
54 51 47 49 108 109 124 122 121 116 26 34
CWIP 3 3 2 2 1 2 0 0 1 12 13 8
Investments 1 1 88 150 76 58 51 73 75 65 65 78
148 147 152 120 140 153 147 160 165 208 87 83
Total Assets 205 203 289 321 325 322 322 354 361 402 191 202

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
10 24 -27 5 -12 -12 24 25 -10 1 94 19
-6 -3 52 -0 19 14 -12 -11 -2 1 -89 -8
-4 -18 -24 -3 -4 -6 -11 -2 -4 -2 -5 -9
Net Cash Flow -0 3 1 2 3 -5 1 12 -16 0 0 2

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 116 105 78 84 90 110 112 111 94 96 100 72
Inventory Days 74 60 46 59 46 58 77 82 67 53 58 56
Days Payable 113 96 86 95 96 84 96 120 76 81 118 113
Cash Conversion Cycle 77 70 38 49 40 84 94 73 84 67 40 15
Working Capital Days 53 45 90 42 44 82 98 83 78 70 39 25
ROCE % 15% 18% 22% 12% 11% 9% 3% 10% 7% 10% 5% 12%

Shareholding Pattern

Numbers in percentages

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
67.49% 67.55% 67.55% 67.54% 67.54% 67.55% 67.55% 67.56% 67.61% 67.63% 67.65% 67.65%
0.57% 0.57% 0.58% 0.57% 0.59% 1.10% 0.94% 0.66% 0.69% 0.81% 0.61% 0.61%
0.83% 0.83% 0.69% 0.69% 0.69% 0.98% 1.18% 1.21% 1.18% 1.26% 1.32% 1.13%
31.10% 31.05% 31.18% 31.20% 31.18% 30.36% 30.32% 30.56% 30.52% 30.30% 30.42% 30.60%
No. of Shareholders 11,08610,0369,4839,4589,4809,81810,14510,84012,42913,40712,97913,488

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents